Cord Blood Stem Cell TransplantationTransplantation, HomologousHematopoietic Stem Cell TransplantationStem Cell TransplantationGraft vs Host DiseaseTransplantation ConditioningHematologic NeoplasmsCytomegalovirus InfectionsRoseolovirus InfectionsAspergillosisHistocompatibility TestingStem CellsCytomegalovirusFetal BloodTreatment OutcomeBone Marrow TransplantationTransplantation, AutologousRetrospective StudiesTissue DonorsTransplantation ChimeraHematopoietic Stem CellsPeripheral Blood Stem Cell TransplantationGraft vs Leukemia EffectGraft SurvivalBusulfanRecurrenceImmunosuppressive AgentsMyeloablative AgonistsVidarabineLeukemiaGraft vs Tumor EffectImmunocompromised HostRemission InductionHistocompatibilityTransplantationLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemia, Myeloid, AcuteWhole-Body IrradiationEmbryonic Stem CellsSpinal CordLymphocyte DepletionTime FactorsOpportunistic InfectionsPrecursor Cell Lymphoblastic Leukemia-LymphomaT-LymphocytesMultiple MyelomaVirus ActivationAntigens, CD34Adult Stem CellsSiblingsSalvage TherapyMycosesHematopoietic Stem Cell MobilizationSurvival AnalysisCombined Modality TherapySurvival RateAnemia, AplasticMyelodysplastic SyndromesChimerismHepatic Veno-Occlusive DiseaseAcute DiseaseHematologic DiseasesMinor Histocompatibility AntigensGraft RejectionCell DifferentiationLymphocyte TransfusionHerpesvirus 6, HumanPluripotent Stem CellsAntilymphocyte SerumGanciclovirImmunosuppressionHLA AntigensLeukocyte TransfusionSpinal Cord InjuriesCells, CulturedFlow CytometryDisease-Free SurvivalNeoplasm, ResidualFatal OutcomeAntiviral AgentsFollow-Up StudiesTransplantation ImmunologyLymphoproliferative DisordersKidney TransplantationAntineoplastic Combined Chemotherapy ProtocolsStem Cell NicheCyclosporinePyrimidinesCyclophosphamideBone Marrow CellsInduced Pluripotent Stem CellsNeural Stem CellsAntifungal AgentsTransplantsMesenchymal Stem Cell TransplantationPrognosisMesenchymal Stromal CellsLeukemia, MyeloidAntineoplastic AgentsMelphalan